Rahul Mittal

Dr. Rahul Mittal

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2024 in Cureus
Verified
Journal Article
Open access
VTVishwa S Thakor
Vishwa S Thakor
ATAnisha Tyagi
Anisha Tyagi
JJJames M Lee Jr.
James M Lee Jr.
FCFrederick Coffman
Frederick Coffman
RMRahul Mittal
Rahul Mittal
Alois Alzheimer was a German psychologist and neuropathologist who significantly advanced the study of dementia with his discovery of Alzheimer’s disease (AD). Based on his assessment of a 51-year-old female patient with symptoms of presenile dementia and after conducting a postmortem autopsy of her brain, Alzheimer distinguished two neurological substances - senile plaques and neurofibrillary tangles - as unique markers of what was later deemed as AD. He recognized that dementia is not a natural consequence of age but rather a recognizable neurocognitive disorder. Despite the long-lasting criticism of his findings, Alzheimer’s discovery fundamentally altered the landscape of neuropathological studies by establishing that AD was a clinically identifiable disease with distinct markers that could be targeted for treatment. Today, modern research on AD continues to build on the foundation laid by Alzheimer’s discovery.

30 January 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
VNVictoria Nguyen
Victoria Nguyen
RMRahul Mittal
Rahul Mittal
Background: Atrial fibrillation (AF) is common among intensive care unit (ICU) patients and is associated with increased mortality, prolonged length of stay (LOS), and greater resource utilization. Widely used AF risk scores were developed for stable outpatient populations and have limited applicability in critically ill patients. This study aimed to (1) characterize ICU patients with AF, (2) develop and temporally externally validate machine learning models to predict ICU mortality and ICU LOS, and (3) identify early clinical factors associated with these outcomes using interpretable methods. Methods: Adult ICU patients with AF from MIMIC-IV (n = 20,058) were used for model development with grouped cross-validation, and MIMIC-III (n = 11,475) served as a temporal external validation cohort. Predictors included demographics, admission characteristics, vital signs, laboratory values, vasoactive support, and AF-related medications available within the first 24 h of ICU admission. Eight classification algorithms were evaluated for ICU mortality, and six regression algorithms were evaluated for ICU LOS. Discrimination was primarily assessed using the area under the receiver operating characteristic curve (AUC) and average precision (AP), with additional threshold-dependent metrics reported to characterize operating-point behavior under low event prevalence. Probability-threshold optimization using out-of-fold predictions was applied to the primary mortality model. LOS performance was evaluated using mean absolute error (MAE), root mean squared error (RMSE), and the coefficient of determination (R2). Model interpretability was assessed using SHapley Additive exPlanations (SHAP). Results: The median age was 75 years, and ICU mortality was 8.9%. For mortality prediction, the XGBoost model demonstrated preserved discrimination on temporal external validation (MIMIC-III) (AUC = 0.743; AP = 0.226). At the default probability threshold (0.50), recall and F1 scores were low due to low event prevalence; applying a prespecified F1-optimized threshold derived from the development cohort improved sensitivity while maintaining overall discrimination. For ICU LOS, models explained little variance on temporal validation; LightGBM performed best, but the explained variance was low (MAE = 88.9 h; RMSE = 163.9 h; R2 = 0.038), indicating that the first 24-h structured data provide an insufficient signal to accurately predict ICU LOS, likely due to downstream clinical and operational factors. SHAP analysis identified clinically plausible predictors of mortality and prolonged ICU stay, including reduced urine output, renal dysfunction, metabolic derangement, hypoxemia, early vasopressor use, advanced age, and admission pathways.

25 December 2025 in British Journal of Hospital Medicine
Verified
Journal Article
Closed access
RMRahul Mittal
Rahul Mittal
ALAngela Man Wai Lai
Angela Man Wai Lai
RCRebecca Coskin
Rebecca Coskin
JKJoshua M Kaplan
Joshua M Kaplan
JDJames Doyle
James Doyle
Hypernatremia, defined as an elevated serum sodium concentration, is a critical electrolyte imbalance with significant neurological and systemic effects. Effective management hinges on understanding the condition’s underlying aetiology, such as dehydration, excessive sodium intake, or impaired renal water handling. The approach to treatment varies by onset and severity: acute hypernatremia (<48 hours) necessitates rapid but controlled correction to prevent complications like vascular rupture or cerebral bleeding, while chronic hypernatremia (≥48 hours) requires gradual intervention to mitigate the risk of cerebral edema. Treatment focuses on restoring water balance through intravenous fluids (typically hypotonic solutions) while monitoring serum sodium levels to prevent overcorrection. Identifying and addressing associated conditions, such as diabetes insipidus (DI) or volume depletion, is crucial. Advances in the understanding of pathophysiology have informed clinical guidelines, emphasizing personalized care based on patient-specific factors, such as age, comorbidities, and the underlying cause of hypernatremia. Despite improvements in treatment protocols, challenges remain in managing hypernatremia in critically ill patients, where both rapid and excessively slow corrections are associated with increased mortality. Further research is needed to refine management strategies, develop predictive biomarkers for better risk assessment, and optimize outcomes in diverse patient populations. This review highlights the importance of a multidisciplinary approach in diagnosing, treating, and preventing complications of hypernatremia, ensuring safer and more effective care delivery.

13 February 2025 in Cureus
Verified
Journal Article
Open access
PDF file
RMRahul Mittal
Rahul Mittal
AKAjith Kumar Kannan
Ajith Kumar Kannan
RMRajnish Mohindroo
Rajnish Mohindroo
CMChakri Movva
Chakri Movva
LZLai Zhang
Lai Zhang
SSShankar Srinivasan
Shankar Srinivasan
Introduction Total triage is a transformative approach to healthcare delivery that uses digital platforms such as Accurx to replace traditional appointment scheduling with a remote-first system. Unlike conventional methods, total triage involves an initial remote assessment - via online forms, calls, or video consultations - to prioritize cases based on urgency and allocate resources more effectively. This system addresses challenges such as long wait times, excessive call volumes, and clinician burnout while improving accessibility and ensuring timely, patient-centered care. This research focuses on the challenges of implementation, particularly patterns of use related to call wait times and patient and staff experiences with the Accurx platform. Methods This retrospective study analyzed routinely collected data from the Bilston Urban Village (BUV) Medical Center between August 2023 and September 2024, focusing on the implementation of the Accurx total triage platform. A mixed-methods approach was employed to provide a comprehensive evaluation of its impact. Quantitative data were collected on call wait time metrics to assess system efficiency and identify patterns of use. Qualitative data were gathered through a patient satisfaction survey, capturing insights into patients’ experiences. Additionally, staff feedback was taken into account to further understand perceived challenges and areas for improvement. Together, these data sources enabled an in-depth analysis of the platform's implementation phase. Results The implementation of the Accurx total triage platform at BUV Medical Center resulted in a 35% reduction in average call wait times compared to pre-implementation levels across all patient demographics, highlighting its efficiency in managing patient demand. Quantitative analysis showed a consistent decrease in wait times over the study period, alongside improved resource utilization. Qualitative data from anonymous patient satisfaction surveys indicated that 58% of respondents found the system easy to use and effective in addressing their healthcare needs. However, 14% reported challenges, including difficulties navigating the platform and delays in responses during peak times. Staff feedback reflected these findings, with the majority emphasizing the platform’s ability to streamline triage and reduce administrative burden while identifying challenges such as the need for better support during high-demand periods. These findings contribute to addressing the broader NHS challenges of managing call volumes and underscore the platform's overall effectiveness while highlighting specific areas for improvement, particularly in accessibility and responsiveness. Conclusion The Accurx total triage platform improved efficiency and patient and staff satisfaction at BUV Medical Center, particularly by reducing call wait times and streamlining access to care. Despite these successes, challenges such as navigation difficulties highlight areas for enhancement. Addressing these barriers and optimizing the system’s functionality will be crucial for sustaining its long-term impact. Overall, the study underscores the potential of digital triage systems to transform healthcare delivery by improving access, resource utilization, and patient experiences.

11 July 2011 in AIP Conference Proceedings
Verified
Conference Paper
Closed access
PDF file
YSY. A. Sorb
Y. A. Sorb
NSN. Subramanian
N. Subramanian
TRT. R. Ravindran
T. R. Ravindran
PSP. Ch. Sahu
P. Ch. Sahu
AGAlka B. Garg
Alka B. Garg
RMR. Mukhopadhyay
R. Mukhopadhyay
GexSn1−x has been predicted to be a direct band‐gap semiconductor, but attempts to synthesize this in bulk form by conventional synthesis methods have not been successful on account of the poor solubility of Sn in Ge. In this work, laser heated diamond anvil cell (LHDAC) technique has been employed to explore formation of bulk GexSn1−x (x = 0.7 ) at varying pressures and temperatures. At ∼8 GPa, in situ micro‐Raman spectroscopy done on several regions of temperature quenched samples laser heated up to ∼2000 K reveals vanishing of the intense Ge TO(Γ) phonon at ∼326 cm−1 and appearance of a softer mode, concurrent with appearance of a new high intensity Raman mode at ∼660 cm−1 . These indicate dilation of the Ge‐Ge bond by virtue of significant miscibility of βSn at these high P‐T conditions and hints at formation of new stiff Ge‐Sn bonds.

24 November 2025 in BJGP Open
Verified
Journal Article
Open access
PDF file
NZNancy Zhang
Nancy Zhang
RMRajnish Mohindroo
Rajnish Mohindroo
PMPraveen Mundlur
Praveen Mundlur
RMRahul Mittal
Rahul Mittal